参考文献/References:
[1] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志,2021,36(6):521-545.
[2] Suslov AV,Chairkina E,Shepetovskaya MD,et al. The neuroimmune role of intestinal microbiota in the pathogenesis of cardiovascular disease[J]. J Clin Med,2021,10(9):1995.
[3] Yu L,Meng G,Huang B,et al. A potential relationship between gut microbes and atrial fibrillation:trimethylamine N-oxide,a gut microbe-derived metabolite,facilitates the progression of atrial fibrillation[J]. Int J Cardiol,2018,255:92-98.
[4] Morais LH,Schreiber HL 4th,Mazmanian SK. The gut microbiota-brain axis in behaviour and brain disorders[J]. Nat Rev Microbiol,2021,19(4):241-255.
[5] Yu CD,Xu QJ,Chang RB. Vagal sensory neurons and gut-brain signaling[J]. Curr Opin Neurobiol,2020,62:133-140.
[6] Mulak A,Bonaz B. Brain-gut-microbiota axis in Parkinson’s disease[J]. World J Gastroenterol,2015,21(37):10609-10620.
[7] Mayer EA,Nance K,Chen S. The gut-brain axis[J]. Annu Rev Med,2022,73:439-453.
[8] Moldovan DC,Ismaiel A,Fagoonee S,et al. Gut microbiota and cardiovascular diseases axis[J]. Minerva Med,202 2,113(1):189-199.
[9] Richards EM,Li J,Stevens BR,et al. Gut microbiome and neuroinflammation in hypertension[J]. Circ Res,2022,130(3):401-417.
[10] Sharma RK,Yang T,Oliveira AC,et al. Microglial cells impact gut microbiota and gut pathology in angiotensinⅡ-induced hypertension[J]. Circ Res,2019,124(5):727-736.
[11] Toral M,Robles-Vera I,de la Visitación N,et al. Critical role of the interaction gut microbiota - sympathetic nervous system in the regulation of blood pressure[J]. Front Physiol,2019,10:231.
[12] Zubcevic J,Richards EM,Yang T,et al. Impaired autonomic nervous system-microbiome circuit in hypertension[J]. Circ Res,2019,125(1):104-116.
[13] Daly DM,Park SJ,Valinsky WC,et al. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse[J]. J Physiol,2011,589(Pt 11):2857-2870.
[14] Nakai M,Ribeiro RV,Stevens BR,et al. Essential hypertension is associated with changes in gut microbial metabolic pathways:a multisite analysis of ambulatory blood pressure[J]. Hypertension,2021,78(3):804-815.
[15] Sévoz C,Nosjean A,Callera JC,et al. Stimulation of 5-HT3 receptors in the NTS inhibits the cardiac Bezold-Jarisch reflex response[J]. Am J Physiol,1996,271(1 Pt 2):H80-H87.
[16] Li J,Raizada MK,Richards EM. Gut-brain-bone marrow axis in hypertension[J]. Curr Opin Nephrol Hypertens,2021,30(2):159-165.
[17] Jackson MA,Verdi S,Maxan ME,et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort[J]. Nat Commun,2018,9(1):2655.
[18] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS):The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC) Developed with the special contribution of the European Heart Rhythm Association(EHRA) of the ESC[J]. Eur Heart J,2021,42(5):373-498.
[19] 中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会,中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动:目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志,2022,26(1):15-88.
[20] Büttner P,Okun JG,Hauke J,et al. Trimethylamine N-oxide in atrial fibrillation progression[J]. Int J Cardiol Heart Vasc,2020,29:100554.
[21] Li XS,Obeid S,Wang Z,et al. Trimethyllysine,a trimethylamine N-oxide precursor,provides near- and long-term prognostic value in patients presenting with acute coronary syndromes[J]. Eur Heart J,2019,40(32):2700-2709.
[22] Gawalko M,Agbaedeng TA,Saljic A,et al. Gut microbiota,dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications[J]. Cardiovasc Res,2021 Sep 22;cvab292.DOI:10.1093/cvr/cvab292.Online ahead of print.
[23] Zhang Y,Zhang S,Li B,et al. Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome[J]. Cardiovasc Res,2022,118(3):785-797.
[24] Linz D,Gawalko M,Sanders P,et al. Does gut microbiota affect atrial rhythm? Causalities and speculations[J]. Eur Heart J,2021,42(35):3521-3525.
[25] John RM,Tedrow UB,Koplan BA,et al. Ventricular arrhythmias and sudden cardiac death[J]. Lancet,2012,380(9852):1520-1529.
[26] Yu L,Zhou L,Cao G,et al. Optogenetic modulation of cardiac sympathetic nerve activity to prevent ventricular arrhythmias[J]. J Am Coll Cardiol,2017,70(22):2778-2790.
[27] Manolis AA,Manolis TA,Apostolopoulos EJ,et al. The role of the autonomic nervous system in cardiac arrhythmias:the neuro-cardiac axis,more foe than friend?[J]. Trends Cardiovasc Med,2021,31(5):290-302.
[28] Meng G,Zhou X,Wang M,et al. Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways[J]. EBioMedicine,2019,44:656-664.
[29] Liu H,Zhuang J,Tang P,et al. The role of the gut microbiota in coronary heart disease[J]. Curr Atheroscler Rep,2020,22(12):77.
[30] Emoto T,Yamashita T,Kobayashi T,et al. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism:gut microbiota could be a diagnostic marker of coronary artery disease[J]. Heart Vessels,2017,32(1):39-46.
[31] von Eckardstein A. Trimethyllysine and trimethylamine-N-oxide—Pathogenic factors or surrogate markers of increased cardiovascular disease risk?[J]. J Intern Med,2020,288(4):484-486.
[32] Heianza Y,Ma W,Didonato JA,et al. Long-term changes in gut microbial metabolite trimethylamine N-oxide and coronary heart disease risk[J]. J Am Coll Cardiol,2020,75(7):763-772.
[33] Elgnemi TS,Jun MB,Songmene V,et al. Milling performance of CFRP composite and atomised vegetable oil as a function of fiber orientation[J]. Materials(Basel),2021,14(8):2062.
[34] Fogelson DL,Kagan BL. Bipolar spectrum disorder masquerading as treatment resistant unipolar depression[J]. CNS Spectr,2022,27(1):4-6.
[35] Pasini E,Aquilani R,Testa C,et al. Pathogenic gut flora in patients with chronic heart failure[J]. JACC Heart Fail,2016,4(3):220-227.
[36] Mamic P,Chaikijurajai T,Tang WHW. Gut microbiome—A potential mediator of pathogenesis in heart failure and its comorbidities:state-of-the-art review[J]. J Mol Cell Cardiol,2021,152:105-117.
[37] Zhang Y,Wang Y,Ke B,et al. TMAO:how gut microbiota contributes to heart failure[J]. Transl Res,2021,228:109-125.
[38] Fudim M,Ponikowski PP,Burkhoff D,et al. Splanchnic nerve modulation in heart failure:mechanistic overview,initial clinical experience,and safety considerations[J]. Eur J Heart Fail,2021,23(7):1076-1084.
[39] Wang G,Kong B,Shuai W,et al. 3,3-Dimethyl-1-butanol attenuates cardiac remodeling in pressure-overload-induced heart failure mice[J]. J Nutr Biochem,2020,78:108341.
相似文献/References:
[1]杨娟,综述,王佑华,等.肠道菌群与血管内炎症[J].心血管病学进展,2016,(3):263.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.012]
YANG Juan,WANG Youhua,YUAN Suyun.Relationship Between Gut Microbiota and Vascular Inflammation[J].Advances in Cardiovascular Diseases,2016,(7):263.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.012]
[2]张琪 宋晓鹏 任茂佳 吴广 赵兴胜.氧化三甲胺与心血管疾病的研究新进展[J].心血管病学进展,2020,(1):81.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.022]
ZHANG Qi,SONG Xiaopeng,REN Maojia,et al.Trimethylamine Oxide and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(7):81.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.022]
[3]李靖,任彭,努尔比耶·买买提,等.三甲胺-N-氧化物与冠心病和心力衰竭的研究进展[J].心血管病学进展,2020,(3):272.[doi:10.16806/j.cnki.issn.1004-3934.2019.00.014]
LI Jing,REN Peng,Nuerbiye·Maimaiti,et al.Trimethylamine-N-oxide and Coronary Heart Disease and Heart Failure[J].Advances in Cardiovascular Diseases,2020,(7):272.[doi:10.16806/j.cnki.issn.1004-3934.2019.00.014]
[4]王猛 江洪.肠道菌群及其代谢产物与心房颤动的研究进展[J].心血管病学进展,2022,(3):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
WANG Meng,JIANG Hong.Gut Microbiota an d Its Metabolites in Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(7):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[5]刘杏利 高中山 段豪亮 赵奕 马玉兰.肠道菌群及其代谢物与心律失常关系的研究进展[J].心血管病学进展,2022,(11):1002.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.009]
LIU Xingli,GAO Zhongshan,DUAN Haoliang,et al.The Relationship Between Intestinal Flora and Its Metabolites and Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(7):1002.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.009]
[6]张嘉原 张莉.果糖代谢与血脂异常的研究进展[J].心血管病学进展,2022,(12):1114.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.013]
ZHANG Jiayuan ZHANG Li.Fructose Metabolism and DyslipidemiaA Systematic Review[J].Advances in Cardiovascular Diseases,2022,(7):1114.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.013]
[7]卢燕 刘亚萍 罗强 张全波 汪汉.肠道菌群及其代谢物与痛风[J].心血管病学进展,2023,(2):177.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.018]
LU Yan,LIU Yaping,LUO Qiang,et al.Intestinal Flora and Its Metabolites and Gout[J].Advances in Cardiovascular Diseases,2023,(7):177.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.018]
[8]蒋振江 刘富强 王军奎.肠道菌群与肥胖的关系研究进展[J].心血管病学进展,2023,(3):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
JIANG Zhenjiang,LIU Fuqiang,WANG Junkui.The Relationship Between Gut Microbiota and Obesity[J].Advances in Cardiovascular Diseases,2023,(7):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
[9]黄露霈 成泽东.肠道微生物细胞外囊泡对心血管系统影响的研究进展[J].心血管病学进展,2023,(4):355.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.015]
UANG Lupei,CHENG Zedong ?/html>.Research Progress on the Effect of Intestinal Microbial?#160Extracellular Vesicles on Cardiovascular System[J].Advances in Cardiovascular Diseases,2023,(7):355.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.015]
[10]柳民 夏健明 王昱冕 赵敏章 邓瑶 任浩博 赵勇 张宇 马润伟.人体菌群与肺动脉高压的研究进展与展望[J].心血管病学进展,2023,(5):453.[doi:10.16806/j.cnki.issn.1004-3934.202.05.016]
LIU Min,XIA Jianming,WANG Yumian,et al.Human Microbiota and Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2023,(7):453.[doi:10.16806/j.cnki.issn.1004-3934.202.05.016]
[11]李帅 刘富强 王军奎.酒精摄入对肠道菌群的影响及其机制研究进展[J].心血管病学进展,2023,(2):172.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.017]
LI ShuaiLIU FuqiangWANG Junkui.Effects of Alcohol Intake on Intestinal Flora and Its Mechanism[J].Advances in Cardiovascular Diseases,2023,(7):172.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.017]